Penetrium™

Immune Modulation Platform

Penetrium™ is not a therapeutic that targets a specific disease, but a platform designed to modulate shared pathological mechanisms characterized by immune imbalance and chronic inflammation. These mechanisms manifest in different forms not only in the immunosuppressive tumor microenvironment, but also in autoimmune and inflammatory diseases. 

 Cross-Disease Mechanism

One Immune Axis, Multiple Diseases

Although cancer and autoimmune diseases are different conditions, both exist along the same axis of immune dysregulation. 

Cancer : a state in which immune activity is excessively suppressed
Autoimmune disease : a state in which immune activity is excessively activated 

By modulating the imbalanced immune microenvironment and inflammatory signaling that drive these two extremes, Penetrium™ targets the underlying mechanism itself rather than the disease type.